Keytruda and Spiriva drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Keytruda (pembrolizumab) and Spiriva (tiotropium bromide monohydrate). Common drug interactions include respiratory failure among females and malignant neoplasm progression among males.
The phase IV clinical study analyzes what interactions people have when they take Keytruda and Spiriva. It is created by eHealthMe based on reports of 145 people who take the same drugs from the FDA, and is updated regularly.
What is Keytruda?
Keytruda has active ingredients of pembrolizumab. It is often used in renal cell carcinoma. eHealthMe is studying from 57,404 Keytruda users. Check the latest studies of Keytruda.
What is Spiriva?
Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 156,666 Spiriva users. Check the latest studies of Spiriva.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
145 people who take Keytruda and Spiriva together, and have interactions are studied.
What are the common drug interactions of Keytruda and Spiriva, by gender? *
What are the common drug interactions of Keytruda and Spiriva, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Keytruda and Spiriva?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Keytruda and Spiriva:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Keytruda:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Spiriva:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keytruda and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Spiriva and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pembrolizumab and tiotropium bromide monohydrate (the active ingredients of Keytruda and Spiriva, respectively), and Keytruda and Spiriva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Isoniazid and Clindamycin Hydrochloride - now
- Could Hydrochlorothiazide cause Drowsiness? - 12 seconds ago
- Could Nplate cause Mouth Haemorrhage? - 13 seconds ago
- Could Dimenhydrinate cause Hypogonadism? - 13 seconds ago
- Could Loraz cause Bladder Dysfunction? - 17 seconds ago
- Drug interactions of Megace and Miralax - 19 seconds ago
- Could Clotrimazole cause Faecal Incontinence? - 19 seconds ago
- Could Ativan cause Injection Site Hypersensitivity? - 27 seconds ago
- Could Romazicon cause Fatigue? - 28 seconds ago
- Could Ativan cause Faeces Hard? - 29 seconds ago